Accessibility Menu
Gerresheimer Ag logo

Gerresheimer Ag(ETR) GXI

Market Cap€959.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-8%
5 Year-69%
1 Year-38%
1 Month-4%
€27.94
+0.58%
+0.16Today
Gerresheimer Ag last closing stock price
MetricPriceDate
Last closeEUR 27.922026-08-18
Gerresheimer Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.05%EUR 27.362026-08-11
1 month-3.92%EUR 29.062026-07-17
3 month+7.88%EUR 25.882026-05-20
Year to date+1.23%EUR 27.582025-12-30
1 year-37.62%EUR 44.762025-08-18
3 year-76.03%EUR 116.502023-08-18
5 year-68.61%EUR 88.952021-08-19
Since inception-7.64%EUR 30.082007-06-11

Gerresheimer Ag Financials at a Glance

Market Cap

€959.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.32B

Net Income (TTM)

-€320.32M

EPS (TTM)

-€9.27

P/E Ratio

-3.00

Dividend

€0.00

Beta (Volatility)

-0.09 (Low)

Price

€27.94

Volume

43,795

Open

€27.60

Previous Close

€27.78

Daily Range

€27.56 - €28.04

52-Week Range

€14.83 - €46.72

Estimated Earnings Date

Oct 1, 2026

GXI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gerresheimer Ag

Gerresheimer AG, founded in 1864 and based in Düsseldorf, Germany, is a global supplier specializing in packaging solutions and sophisticated drug delivery systems. The company operates through three distinct divisions, serving the pharmaceutical, biotech, diagnostics, and medical technology sectors.

Products and Services
  • Plastics & Devices: Inhalers, insulin pen systems, and prefillable syringes
  • Primary Packaging Glass: Glass bottles, vials, and ampoules for pharmaceuticals and cosmetics
  • Advanced Technologies: Intelligent drug delivery systems, including micro pumps for self-administration
Growth Outlook
  • Strong demand for drug delivery systems is expected to drive revenue growth
  • Expansion into emerging markets presents significant growth opportunities
  • Investment in R&D aims to enhance product offerings and innovation
Financial Highlights
  • Recent quarterly revenue of €639.5 million shows a positive trend
  • Trailing twelve months (TTM) revenue of €2.4 billion indicates strong market presence
  • Operating income margin improved to -0.51% in the latest quarter
Gerresheimer AG is positioned in a growing market, driven by increasing healthcare demands and innovations in drug delivery systems. The company's diverse product portfolio and commitment to research and development enhance its competitive edge. Recent financial performance reflects resilience, with a notable revenue increase in the latest quarter. The focus on expanding into emerging markets and enhancing product offerings through R&D investments further supports a positive growth trajectory. Investors may find Gerresheimer AG an intriguing option within the healthcare sector, given its established market presence and strategic growth initiatives.
AI Generated • Aug 12, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

13,528

CEO

Uwe Ferdinand Röhrhoff

Website

www.gerresheimer.com

Headquarters

Düsseldorf, NW 40468, DE

GXI Financials

Key Financial Metrics (TTM)

Gross Margin

18.32%

Operating Margin

-9.02%

Net Income Margin

-13.80%

Return on Equity

-23.57%

Return on Capital

-7.81%

Return on Assets

-7.13%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

-1.05%

Stock Overview

Market Cap

€959.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

34.54M

Volume

43.80K

Avg. Volume

182.93K

Financials (TTM)

Gross Profit

€425.25M

Operating Income

-€209.32M

EBITDA

€312.91M

Operating Cash Flow

€209.53M

Capital Expenditure

-€669.91M

Free Cash Flow

-€98.80M

Cash & ST Invst.

€176.21M

Total Debt

€1.60B

Gerresheimer Ag Performance Analysis

Gerresheimer Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-11-30EUR 1,817,094,00021.3%
20232023-11-30EUR 1,990,486,0009.5%
20242024-11-30EUR 1,991,269,0000.0%
20252025-11-30EUR 2,320,885,00016.6%
Gerresheimer Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-02-28-8.6%
Q22025-05-3115.5%
Q32025-08-31-6.7%
Q42025-11-3014.1%
Gerresheimer Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-11-30EUR 3.0614.7%
20232023-11-30EUR 3.4813.8%
20242024-11-30EUR 2.38-31.6%
20252025-11-30EUR -9.27N/A
Gerresheimer Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-02-28-148.6%
Q22025-05-31194.2%
Q32025-08-31-175.5%
Q42025-11-30-2300.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

€639.49M

+12.4%

Gross Profit

€1.78M

-99.0%

Gross Margin

0.28%

N/A

Market Cap

€959.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€70.93K

N/A

Employees

13,528

N/A

Net Income

-€306.63M

-927.8%

EBITDA

€35.02M

-70.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

€176.21M

-17.3%

Total Debt

€1.60B

+24.8%

Accounts Receivable

€342.64M

-15.3%

Inventory

€450.36M

+28.8%

Long Term Debt

€1.60B

+74.7%

Short Term Debt

€0.00

-100.0%

Return on Assets

-7.13%

N/A

Return on Invested Capital

-6.68%

N/A

Free Cash Flow

€31.83M

-27.5%

Operating Cash Flow

€89.74M

-32.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,754.42-0.00%
^DJIDJI
$53,461.25-0.01%
^IXICNASDAQ
$26,653.02-0.00%
BTCBitcoin
$64,341.00+0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$43.90+0.14%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$129.73-0.14%
NOKNokia
$10.39-0.04%
INTCIntel
$97.01-0.06%

Questions About GXI

What is the current price of Gerresheimer Ag?

Gerresheimer Ag is trading at €27.94 per share.

What is the 52-week range for Gerresheimer Ag?

Over the past 52 weeks, Gerresheimer Ag has traded between €14.83 and €46.72.

How much debt does Gerresheimer Ag have?

As of the most recent reporting period, Gerresheimer Ag reported total debt of €2.18B.

How much cash does Gerresheimer Ag have on hand?

Gerresheimer Ag reported €176.21M in cash and cash equivalents in its most recent financial results.

What is Gerresheimer Ag’s dividend yield?

Gerresheimer Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services